3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow KX2-391: new trials by email Literature Review of KX2-391 trials Research Report on KX2-391
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML) KX2-391 - Acute Myelogenous Leukemia | Phase 1 | Completed | Kinex Pharmaceuticals Inc. | 24 | 2013-12-01 | 2015-12-07 |
| Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer KX2-391 - Bone-Metastatic, Castration-Resistant Prostate Cancer | Phase 2 | Completed | Athenex, Inc. | 31 | 2010-02-01 | 2023-02-02 |
| Evaluation of KX2-391 in Patients With Advanced Malignancies KX2-391 - Solid Tumors, Lymphoma | Phase 1 | Completed | Athenex, Inc. | 50 | 2007-11-01 | 2011-06-08 |
Leukemia, Myeloid, Acute (1) · Lymphoma (1)
Athenex, Inc. (2) · Kinex Pharmaceuticals Inc. (1)
United States (3)
Aung Naing, M.D. (1) · James Thompson, MD (1) · Michael Carducci, MD (1) · Min-Fun Rudolf Kwan, MD (1) · Roger B Cohen, M.D. (1)